- ►annals.org KE Donahue, G Gartlehner, DE Jonas, LJ Lux … - Annals of Internal Medicine, 2007 - Am Coll Physicians A more recent version of this article appeared on January 15, 2008. ...
Background: The comparative effectiveness of rheumatoid arthritis therapies is
uncertain. ... Purpose: To compare the benefits and harms of ... Cited by 56 - Related articles - BL Direct - All 13 versions
[CITATION] Systematic Review: Comparative Effectiveness and Harms of Disease-Modifying Medications …
JS Smolen, D Aletaha, E Keystone - Arthritis and rheumatism, 2005 - cat.inist.fr Superior efficacy of combination therapy for rheumatoid arthritis: Fact
or fiction? Josef S SMOLEN, Daniel ALETAHA, Edward KEYSTONE ... Cited by 59 - Related articles - All 3 versions
- ►oxfordjournals.org EHS Choy, C Smith, CJ Dore, DL Scott - Rheumatology, 2005 - Br Soc Rheumatology Method. Medline, PubMed and EmBase were searched using MESH headlines
'arthritis, rheumatoid', 'drug therapy, combination' and 'randomized controlled
trial' (RCT) for papers published from 1975 to April 2004. References from ... Cited by 50 - Related articles - BL Direct - All 6 versions
JR Kalden, JS Smolen, P Emery, PLCM van … - The Journal of Rheumatology, 2004 - jrheum.org In most studies of disease modifying antirheumatic drug therapy, in combination
with either leflunomide or biological agents, patients are given an additional
agent after they have failed treatment with methotrexate (MTX). This review ... Cited by 21 - Related articles - BL Direct - All 9 versions
T Karger, R Rau - Deutsche medizinische Wochenschrift (1946), 1988 - ncbi.nlm.nih.gov Methotrexate, 7.5-25.0 mg, was taken in a single weekly dose by 101 patients
with chronic rheumatoid arthritis. In the course of treatment there was
significant improvement in pain and mobility, as well as in the number of ... Cited by 4 - Related articles
[CITATION] de, VH, van Denderen, JC, Dijkmans, BAC, Aarden, LA and van der Horst-Bruinsma IE. …
